Health Care Providers & Services (29) | License Agreements (29)
Browse by Company
Recent Contracts
-
Exclusive License Agreement with BioE LLC
(CRYO CELL INTERNATIONAL INC, Filed With SEC on April 4, 2022)
-
First Amendment to License Agreement with BioE LLC
(CRYO CELL INTERNATIONAL INC, Filed With SEC on April 4, 2022)
-
Inter-Company License Agreement by and between BioCorRx Inc. and BioCorRx Pharmaceuticals, Inc., effective September 22, 2021
(BioCorRx Inc., Filed With SEC on March 31, 2022)
-
First Amendment to License Agreement
(CRYO CELL INTERNATIONAL INC, Filed With SEC on February 22, 2022)
-
Blue Cross License Agreement by and between Blue Cross Blue Shield Association and the Company, including revisions, if any, adopted by the Member Plans through September 23, 2021
(Anthem, Filed With SEC on February 16, 2022)
-
Blue Shield License Agreement by and between Blue Cross Blue Shield Association and the Company, including revisions, if any, adopted by the Member Plans through September 23, 2021
(Anthem, Filed With SEC on February 16, 2022)
-
Amended and Restated Master Facility License Agreement, dated December 15, 2021, by and between LAF Canada Company and Novo Healthnet Limited
(Novo Integrated Sciences, Inc., Filed With SEC on January 18, 2022)
-
First Amendment to the Non-Exclusive License Agreement between Bio-Rad Laboratories, Inc., and Biodesix, Inc., dated May 24, 2021
(BIODESIX INC, Filed With SEC on August 10, 2021)
-
Patent and License Technology Agreement
(CRYO CELL INTERNATIONAL INC, Filed With SEC on April 14, 2021)
-
Blue Cross License Agreement by and between Blue Cross Blue Shield Association and the Company, including revisions, if any, adopted by the Member Plans through September 17, 2020
(Anthem, Filed With SEC on February 18, 2021)